Abstract
A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1. A mechanism of slowed atrial flutter rate and improved atrioventricular nodal conduction, similar to that recognised with quinidine, is suggested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Befeler B., Castellanos A., Jr, Wells D. E., Vagueiro M. C., Yeh B. K. Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate. Am J Cardiol. 1975 Feb;35(2):282–287. doi: 10.1016/0002-9149(75)90014-4. [DOI] [PubMed] [Google Scholar]
- Heel R. C., Brogden R. N., Speight T. M., Avery G. S. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs. 1978 May;15(5):331–368. [PubMed] [Google Scholar]
- Josephson M. E., Caracta A. R., Lau S. H., Gallagher J. J., Damato A. N. Electrophysiological evaluation of disopyramide in man. Am Heart J. 1973 Dec;86(6):771–780. doi: 10.1016/0002-8703(73)90280-9. [DOI] [PubMed] [Google Scholar]
- Meltzer R. S., Robert E. W., McMorrow M., Martin R. P. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. Am J Cardiol. 1978 Dec;42(6):1049–1053. doi: 10.1016/0002-9149(78)90694-x. [DOI] [PubMed] [Google Scholar]